Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device zaps away acid reflux – but is it safe Long-Term?

NCT ID NCT02441400

Disease control Sponsor: EndoStim Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracked 350 people with GERD who received a device that electrically stimulates the muscle that keeps stomach acid from rising. The goal was to see how safe the device is over 5 years and whether it improves symptoms and quality of life. The registry included both new and past implant patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

350 people

The number who actually took part.

Start date

May 2013

Finished

Jul 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects with a diagnosis of GERD who are undergoing or have already undergone EndoStim LES stimulation system implantation.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subject meets therapy indications 2. Subject signs informed consent 3. Subject has a planned EndoStim LES Stimulation System implant (prospective) OR subject has already had EndoStim LES Stimulation System implant (retrospective) Exclusion Criteria: 1\. Subject meets therapy contraindications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERD

Contacts and locations

Locations

  • Aarhus University Hospital

    Aarhus, Denmark

  • Asklepios Klinik Altona

    Hamburg, Germany

  • Asklepios Schwalm-Eder Kliniken GmbH

    Schwalmstadt, Germany

  • Ev. Krankenhaus Wesel GmbH

    Wesel, Germany

  • Evangelisches Krankenhaus Castrop-Rauxel

    Castrop-Rauxel, Germany

  • Evangelisches Krankenhaus Herne

    Herne, Germany

  • Friedrich-Ebert-Krankenhaus Neumünster

    Neumünster, Germany

  • Fundacion Favaloro

    Buenos Aires, Argentina

  • Heilig Geist-Krankenhaus Köln

    Cologne, Germany

  • Hospital San José

    Monterrey, Mexico

  • Hospital zum Heiligen Geist Fritzlar

    Fritzlar, Germany

  • Jung Stilling - Siegen

    Siegen, Germany

  • KRH Klinikum Siloah Hannover Oststadt

    Hanover, Germany

  • Klinikum Garmisch-Partenkirchen

    Garmisch-Partenkirchen, Germany

  • Klinikum Konstanz

    Konstanz, Germany

  • Klinikum Memmingen

    Memmingen, Germany

  • Klinikum Minden Johannes Wesling

    Minden, Germany

  • Klinikum Muenchen Bogenhausen

    München, Germany

  • Klinikum Stuttgart, Krankenhaus Bad Cannstatt

    Stuttgart, Germany

  • Maastricht University Medical Center

    Maastricht, Netherlands

  • Martha Maria Krankenhaus Halle-Dölau

    Halle, Germany

  • SANA Klinikum Lichtenberg

    Berlin, Germany

  • Spire Leicester Hospital

    Leicester, United Kingdom

  • St. Marien-Krankenhaus Siegen

    Siegen, Germany

  • St. Marienstift Krankenhaus Friesoythe

    Friesoythe, Germany

  • University Hospital Southampton

    Southampton, United Kingdom

  • University Hospital Vienna

    Vienna, Austria

  • Universitätsklinikum Magdeburg

    Magdeburg, Germany

  • Universitätsmedizin Mannheim

    Mannheim, Germany

  • Wolfartklinik Graefelfing

    Gräfelfing, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.